References
- Lipinski CA , LombardoF, DominyBW, FeeneyPJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings.Adv. Drug Deliv. Rev.23(1–3), 3–25 (1997).
- Zhang M -Q, Wilkinson B. Drug discovery beyond the ‘rule-of-five‘. Curr. Opin. Biotechnol.18(6), 478–488 (2007).
- Leeson PD , SpringthorpeB. The influence of drug-like concepts on decision-making in medicinal chemistry.Nat. Rev. Drug Discov.6(11), 881–890 (2007).
- Hughes JD , BlaggJ, PriceDA, BaileySet al. Physicochemical drug properties associated with in vivo toxicological outcomes. Bioorg. Med. Chem. Lett. 18(17), 4872–4875 (2008).
- Waring MJ . Lipophilicity in drug discovery.Expert Opin. Drug Discov.5(3), 235–248 (2010).
- van de Waterbeemd H . Physicochemical approaches to drug absorption. In: Drug bioavailability: estimation of solubility, permeability, absorption and bioavailability, Volume 40, 2nd Edition. van de Waterbeemd H, Testa B (Eds). Wiley-VCH Verlag GmbH and Co., Weinheim, Germany, 71–99 (2009).
- Arnott JA , PlaneySL. The influence of lipophilicity in drug discovery and design.Expert Opin. Drug Discov.7(10), 863–875 (2012).
- Kramer C , TilmannH, FliggeT, BeckB, ClarkT. A consistent dataset of kinetic solubilities for early-phase drug discovery.ChemMedChem4(9), 1529–1536 (2009).
- Waring MJ . Defining optimum lipophilicity and molecular weight ranges for drug candidates-molecular weight dependent lower log D limits based on permeability.Bioorg. Med. Chem. Lett.19(10), 2844–2851 (2009).
- Johnson TW , DressKR, EdwardsM. Using the golden triangle to optimize clearance and oral absorption.Bioorg. Med. Chem. Lett.19(19), 5560–5564 (2009).
- Peters J -U, Schnider P, Mattei P, Kansy M. Pharmacological promiscuity: dependence on compound properties and target specificity in a set of recent Roche compounds. ChemMedChem4(4), 680–686 (2009).
- Leeson PD , DavisAM. Time-related differences in the physical property profiles of oral drugs.J. Med. Chem.47(25), 6338–6348 (2004).
- Edwards MP , PriceDA. Role of physicochemical properties and ligand lipophilicity efficiency in addressing drug safety risks.Ann. Reports Med. Chem.45, 381–391 (2010).